Vireo Growth (VREOF) Change in Inventory (2020 - 2026)
Vireo Growth (VREOF) reported Change in Inventory of $2.2 million for Q1 2026, up 10.0% on a YoY basis from $2.0 million in Q1 2025, and down 65.12% sequentially from $6.3 million in Q4 2025.
Vireo Growth (VREOF) Change in Inventory (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Change in Inventory data on file, last reported at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 10.0% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.9 million (up 89.83% YoY), and the FY2025 full-year result was $8.7 million, up 263.95% from the prior year.
- Change in Inventory eased to $2.2 million in Q1 2026, from $6.3 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $6.3 million in Q4 2025 to a low of -$3.3 million in Q2 2025.
- A 5-year average of $1.1 million and a median of $706986.0 in 2024 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 4833.61% in 2025, while the deepest fall reached 563.48% in 2025.
- Tracing VREOF's Change in Inventory over 5 years: stood at $1.8 million in 2022, then sank by 106.11% to -$109163.0 in 2023, then jumped by 1849.33% to $1.9 million in 2024, then soared by 230.34% to $6.3 million in 2025, then plunged by 65.12% to $2.2 million in 2026.
- Business Quant data shows VREOF's Change in Inventory at $2.2 million in Q1 2026, $6.3 million in Q4 2025, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 6.31 Mn |
| Dec 31, 2025 | 6.31 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 74,458.00 |
| Sep 30, 2024 | 74,458.00 |
| Jun 30, 2024 | 706,986.00 |
| Jun 30, 2024 | 706,986.00 |
| Mar 31, 2024 | -299,252.00 |
| Mar 31, 2024 | -299,252.00 |
| Dec 31, 2023 | -109,163.00 |
| Dec 31, 2023 | -109,163.00 |